ADVERTISEMENT

Psychedelics News

psilocybin

Industry

28 Jul 2026

FDA’s New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.

For years, the psychedelic medicine industry has operated in largely uncharted regulatory territory. Companies developing psilocybin, LSD, MDMA, and next-generation psychedelic-inspired compounds have often found themselves navigating a clinical landscape...

By Madison Roberts

Law & Politics

23 Sep 2025

Psylutions and the DEA

In August 2025, the psychedelics movement crossed an unprecedented threshold. The U.S. Drug Enforcement Administration (DEA) announced that it would forward a petition to reschedule psilocybin, the psychoactive compound found...

By Madison Roberts

Law & Politics

9 Dec 2023

US Congress Adds Psychedelics Studies to Defense Bill

A bipartisan group of congressional lawmakers from both the House and the Senate have added funding for studies of psychedelic therapies into a major defense bill....

By Jason Najum

Science

27 Nov 2023

New Study Looks at Shame, Guilt and the Psychedelic Experience

A new study looks at emotionally painful, shame-related processes with psychedelic use....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Science

19 Sep 2023

New Johns Hopkins’ Study Shows Psilocybin Promotes Mental Health Improvements

A new study published by researchers from Johns Hopkins shows that psilocybin produces lasting improvements in mental health symptoms and general well-being....

By Microdose NewsDesk

Don’t Miss

5 Sep 2023

News You Might Have Missed: Sep 5th, 2023

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed....

By Microdose NewsDesk

Science

1 Sep 2023

Usona Publishes Results of Phase 2 Psilocybin Trial for Depression

Results of the Usona Institute’s Phase 2 trial using psilocybin for depression were published yesterday....

By Microdose NewsDesk

mushrooms

Science

31 Aug 2023

New Johns Hopkins Study Shows Psilocybin Helps Long Term Mental Health

A new study from Johns Hopkins shows that psilocybin use promotes positive long-term effects on well-being....

By Jason Najum

Industry

15 Aug 2023

Cybin Granted U.S. Patent For Psilocybin Program

Newly granted U.S. patent covers composition of matter claims and treatment methods in support of the Company’s CYB003 program until 2041...

By Microdose NewsDesk

ADVERTISEMENT

Follow us on social

Latest News

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads